Company Overview

PHIO PHARMACEUTICALS CORP.

PHIO
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-9M
2025 FY
Shares Outstanding
6M
2025 FY
EPS
-1.45USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1533040
Exchange
Nasdaq
Location
US